bibn 99 has been researched along with Aging in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meaney, MJ; O'Donnell, JP; Pearson, D; Quirion, R; Rose, GM; Rowe, WB | 1 |
| Aubert, I; Doods, H; Meaney, MJ; Parent, A; Quirion, R; Richard, J; Rowe, W; White, N; Wilson, A | 1 |
2 other study(ies) available for bibn 99 and Aging
| Article | Year |
|---|---|
Long-term effects of BIBN-99, a selective muscarinic M2 receptor antagonist, on improving spatial memory performance in aged cognitively impaired rats.
Topics: Aging; Analysis of Variance; Animals; Behavior, Animal; Cognition Disorders; Dibenzazepines; Male; Maze Learning; Memory; Movement; Muscarinic Antagonists; Pyridines; Rats; Rats, Long-Evans; Reaction Time; Time; Time Factors | 2003 |
Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired.
Topics: Acetylcholine; Aging; Animals; Cognition; Dibenzazepines; Male; Maze Learning; Memory Disorders; Muscarinic Antagonists; Parasympatholytics; Pirenzepine; Pyridines; Rats; Rats, Inbred Strains; Scopolamine | 1995 |